All Stories

  1. Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

    Article • Journal of Hepatocellular Carcinoma, October 2014, Taylor & Francis

    Dr Alex Graham

  2. Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs

    Article • Oncolytic Virotherapy, December 2013, Taylor & Francis

    Dr Alex Graham